Select Page
New Rules for Listing Biotech Companies on the Hong Kong Stock Exchange

Hong Kong Law

April 2018

Boutique Transactional Law Firm of the Year 2017

Asian Legal Business Awards

This newsletter is for information purposes only.

Its contents do not constitute legal advice and it should not be regarded as a substitute for detailed advice in individual cases.
Transmission of this information is not intended to create and receipt does not constitute a lawyer-client relationship between Charltons and the user or browser.
Charltons is not responsible for any third party content which can be accessed through the website.

If you do not wish to receive this newsletter please let us know by emailing us at

Dominion Centre,12th Floor
43-59 Queen’s Road East Hong Kong

Tel: + (852) 2905 7888
Fax: + (852) 2854 9596


Charltons - Hong Kong Law - 404 - 24 April 2018

Biotech companies listing in Hong Kong

R&D for Core Products

New Rules for biotech companies

Amendments to Hong Kong Listing Rules

Listing Regime for Companies from Emerging and Innovative Sectors

Hong Kong Stock Exchange consultation conclusions

Pre-revenue biotech companies

Hong Kong Listing Rule Chapter 18A
Biotech company risk disclosure
Importance of biotechnology companies
Biotechnology core supporting product
HKEX consultation conclusion
stock exchange consultation paper
HKEX market consultations